Key facts
- This page summarizes Alamar HoldCo, LLC's Form 3 filing for Attovia Therapeutics, Inc. (ATTO).
- 0 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 05 Aug 2026, 19:19.
Alamar HoldCo, LLC - 04 Aug 2026 Form 3 Insider Report for Attovia Therapeutics, Inc. (ATTO)
- Reporting relationship
- 10%+ Owner
- Issuer ticker
- ATTO
- Reported as of
- 04 Aug 2026
- Net transaction value
- $0
- Reporting owner signature
- Yuling Luo, President
Source evidence
Original filing metadata and source links for verification.
3 source fields
Reporting owner
1 detail
Key filing fact
Alamar HoldCo, LLC filed Form 3 for Attovia Therapeutics, Inc. (ATTO) on 05 Aug 2026.
Change
- No earlier filing in this sequence is available for direct comparison.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Official SEC source
View source filing
Ownership activity is grounded in SEC Form 3 disclosures.
Reporting Owners (1)
CIK 0002148983
Primary reporting owner
Alamar HoldCo, LLC
- Relationship
- 10%+ Owner
- Address
- 47071 BAYSIDE PARKWAY, FREMONT
- Signature
- Yuling Luo, President
- Signature date
- 05 Aug 2026
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
ATTO
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 3,229,278
- Date
- 04 Aug 2026
- Ownership
- Direct
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
SEC remarks
In connection with the closing of the Issuer's initial public offering, the Reporting Entity will cease to be a 10% holder.